Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Description of key information

A study was performed to assess the contact sensitisation potential of the test material consisting of 45%decylphosphoric acid, potassium salt (CAS 68427-32-7)in the albino guinea pig. The study was performed essentially similar to the current OECD guideline 406; however control animals were not used. Ten test animals were used for the main study. Based on the results of sighting tests, the concentrations of test material for the induction and challenge phases were selected as follows:

lntradermal lnduction: 0.1% v/v

Topical Induction: 10% v/v

Topical Challenge: 5% v/v

The test material consisting of 45%decylphosphoric acid, potassium salt (CAS 68427-32-7), did not induce dermal irritation after the challenge application in any of the animals and was, therefore, classified as a non-sensitiser to guinea pig skin according to OECD-GHS.

Key value for chemical safety assessment

Skin sensitisation

Link to relevant study records
Reference
Endpoint:
skin sensitisation: in vivo (non-LLNA)
Type of information:
experimental study
Adequacy of study:
key study
Study period:
October-November 1974
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: Limited reported study with only basic data given; comparable to guideline/standard
Qualifier:
equivalent or similar to guideline
Guideline:
OECD Guideline 406 (Skin Sensitisation)
Deviations:
yes
Remarks:
no control group was used
GLP compliance:
no
Remarks:
pre-GLP
Type of study:
guinea pig maximisation test
Justification for non-LLNA method:
SInce a guinea pig maximisation study is already available, a LLNA study has not been performed
Species:
guinea pig
Strain:
Dunkin-Hartley
Sex:
female
Details on test animals and environmental conditions:
TEST ANIMALS
- Source: Redfern Animal Breeders Ltd., Brenchley, Kent, UK
- Age at study initiation: no info
- Weight at study initiation: no info
- Housing: suspended cages with wiremesh floor (no info on number per cage)
- Diet (e.g. ad libitum): ad lib
- Water (e.g. ad libitum): ad lib
- Acclimation period: no info


ENVIRONMENTAL CONDITIONS
- Temperature (°C): no info
- Humidity (%): no info
- Air changes (per hr): no info
- Photoperiod (hrs dark / hrs light): no info


IN-LIFE DATES: From: October To: November 1974
Route:
intradermal and epicutaneous
Vehicle:
water
Concentration / amount:
Intradermal induction: 0.1% v/v
Topical induction: 10% v/v
Topical challenge: 5% v/v
Route:
epicutaneous, occlusive
Vehicle:
water
Concentration / amount:
Intradermal induction: 0.1% v/v
Topical induction: 10% v/v
Topical challenge: 5% v/v
No. of animals per dose:
10 (test group)
Details on study design:
RANGE FINDING TESTS: intradermal and topical irritancy was tested of a range of aqueous dilutions (no further info). 0.1% v/v and 10% v/v weres selected for intreadermal and topical induction, respectively.

MAIN STUDY
A. INDUCTION EXPOSURE
- No. of exposures: single injection (with and without FCA) and topical application
- Exposure period: day 0 and day 7, respectively
- Test groups: yes
- Control group: not used
- Site: shoulder region
- Duration: single injection and 48 h occlusive application
- Concentrations: 0.1% v/v and 10% v/v, respectively

B. CHALLENGE EXPOSURE
- No. of exposures: 1
- Day(s) of challenge: day 21
- Exposure period: 24 h occlusive
- Test groups: yes
- Control group: not used
- Site: flanks
- Concentrations: 5% v/v
- Evaluation (hr after challenge): 24, 48 and 72 h after patch removal

OTHER:
EVALUATION OF SKIN REACTIONS
Erythema and eschar formation
No erythema 0
Very slight erythema (barely perceptible) 1
Well-defined erythema 2
Moderate to severe erythema 3
Severe erythema (beet redness) to slight eschar
formation (injuries in depth) 4

Oedema formation
No oedema 0
Very slight oedema (barely perceptible) 1
Slight oedema (edges of area well-defined by
definite raising) 2
Moderate oedema (raised approximately 1 mm) 3
Severe oedema (raised more than 1 mm and
extending beyond area of exposure) 4

Challenge controls:
No controls were used
Positive control substance(s):
no
Positive control results:
Not used
Reading:
1st reading
Hours after challenge:
24
Group:
test chemical
Dose level:
5% v/v
No. with + reactions:
0
Total no. in group:
10
Clinical observations:
see below
Remarks on result:
other: Reading: 1st reading. . Hours after challenge: 24.0. Group: test group. Dose level: 5% v/v. No with. + reactions: 0.0. Total no. in groups: 10.0. Clinical observations: see below.
Reading:
2nd reading
Hours after challenge:
48
Group:
test chemical
Dose level:
5% v/v
No. with + reactions:
0
Total no. in group:
10
Remarks on result:
other: Reading: 2nd reading. . Hours after challenge: 48.0. Group: test group. Dose level: 5% v/v. No with. + reactions: 0.0. Total no. in groups: 10.0.
Interpretation of results:
not sensitising
Remarks:
Migrated information
Conclusions:
Based on the results of the present test, although no control group was used, the test compound is not a sensitiser to guinea pig skin.
Executive summary:

A study was performed to assess the contact sensitisation potential of of the test material consisting of 45%decylphosphoric acid, potassium salt (CAS 68427-32-7) in the albino guinea pig. The study was performed essentially similar to the current OECD guideline 406; howver control animals were not used. Ten test animals were used for the main study. Based on the results of sighting tests, the concentrations of test material for the induction and challenge phases were selected as follows:

lntradermal lnduction: 0.1% v/v

Topical Induction: 10% v/v

Topical Challenge: 5% v/v

The test material consisting of 45%decylphosphoric acid, potassium salt (CAS 68427-32-7) did not induce dermal irritation after the challenge application in any of the animals and was, therefore, classified as a non-sensitiser to guinea pig skin according to OECD-GHS.

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not sensitising)
Additional information:

A study performed to assess the contact sensitisation potential of the test material in the albino guinea pig. The study was performed essentially similar to the current OECD guideline 406.

The test material did not induce dermal irritation after the challenge application in any of the animals and was, therefore, classified as a non-sensitiser to guinea pig skin according to OECD-GHS.

Respiratory sensitisation

Endpoint conclusion
Endpoint conclusion:
no study available
Additional information:

There are no guidelines for an animal test for respiratory sensitization, however in general respiratory sensitizers are also skin sensitizers. Based on available data ondecylphosphoric acid, potassium salt (CAS 68427-32-7)the substance was not found to be a skin sensitizer. This indicates that the substance is unlikely to possess any significant potential for respiratory sensitization. Decylphosphoric acid, potassium salt (CAS 68427-32-7)is manufactured and marketed as an aqueous solution, therefore inhalation exposure is unlikely.

Justification for classification or non-classification

Skin

Decylphosphoric acid, potassium salt (CAS 68427-32-7)is not found to be a skin sensitizer when tested similar to the current OECD guideline 406.

Inhalation 

Decylphosphoric acid, potassium salt (CAS 68427-32-7)the substance was not found to be a skin sensitizer. This indicates that the substance is unlikely to possess any significant potential for respiratory sensitization. Decylphosphoric acid, potassium salt (CAS 68427-32-7)is manufactured and marketed as an aqueous solution, therefore inhalation exposure is unlikely.

Data on acute inhalation is lacking, but taken the result from the skin sensitization study and the low potential for inhalation exposure into consideration, the substance it is not classified as a respiratory sensitizer.